These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29767567)

  • 1. Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis.
    Gassó P; Mas S; Bioque M; Cabrera B; Lobo A; González-Pinto A; Díaz-Caneja CM; Corripio I; Vieta E; Castro-Fornieles J; Sarró S; Mané A; Sanjuan J; Llerena A; Lafuente A; Saiz-Ruiz J; Bernardo M;
    J Psychopharmacol; 2018 Jun; 32(6):702-710. PubMed ID: 29767567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.
    Mas S; Gassó P; Lafuente A; Bioque M; Lobo A; Gonzàlez-Pinto A; Olmeda MS; Corripio I; Llerena A; Cabrera B; Saiz-Ruiz J; Bernardo M;
    Pharmacogenomics J; 2016 Oct; 16(5):439-45. PubMed ID: 27272046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis.
    Miura I; Zhang JP; Hagi K; Lencz T; Kane JM; Yabe H; Malhotra AK; Correll CU
    Psychoneuroendocrinology; 2016 Oct; 72():1-10. PubMed ID: 27333159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents.
    Calarge CA; Ellingrod VL; Acion L; Miller DD; Moline J; Tansey MJ; Schlechte JA
    Pharmacogenet Genomics; 2009 May; 19(5):373-82. PubMed ID: 19339912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association study of candidate genes with obesity and metabolic traits in antipsychotic-treated patients with first-episode psychosis over a 2-year period.
    Gassó P; Arnaiz JA; Mas S; Lafuente A; Bioque M; Cuesta MJ; Díaz-Caneja CM; García C; Lobo A; González-Pinto A; Parellada M; Corripio I; Vieta E; Castro-Fornieles J; Mané A; Rodríguez N; Boloc D; Saiz-Ruiz J; Bernardo M;
    J Psychopharmacol; 2020 May; 34(5):514-523. PubMed ID: 32009515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in prolactin levels in emerging psychosis: Indication for enhanced stress reactivity in women.
    Ittig S; Studerus E; Heitz U; Menghini-Müller S; Beck K; Egloff L; Leanza L; Andreou C; Riecher-Rössler A
    Schizophr Res; 2017 Nov; 189():111-116. PubMed ID: 28214176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients.
    Houston JP; Fijal B; Heinloth AN; Adams DH
    Psychiatry Res; 2010 Jan; 175(1-2):171-2. PubMed ID: 19896213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the Taq1A variant in the dopamine D₂ receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys.
    Roke Y; van Harten PN; Franke B; Galesloot TE; Boot AM; Buitelaar JK
    Pharmacogenet Genomics; 2013 Sep; 23(9):487-93. PubMed ID: 23851570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics.
    Ivanova SA; Osmanova DZ; Boiko AS; Pozhidaev IV; Freidin MB; Fedorenko OY; Semke AV; Bokhan NA; Kornetova EG; Rakhmazova LD; Wilffert B; Loonen AJ
    Schizophr Res; 2017 Apr; 182():110-114. PubMed ID: 27776952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.
    Peuskens J; Pani L; Detraux J; De Hert M
    CNS Drugs; 2014 May; 28(5):421-53. PubMed ID: 24677189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent clinical aspects of hyperprolactinemia induced by antipsychotics.
    Milano W; D'Acunto CW; De Rosa M; Festa M; Milano L; Petrella C; Capasso A
    Rev Recent Clin Trials; 2011 Jan; 6(1):52-63. PubMed ID: 20868350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia.
    Charan A; Shewade DG; Rajkumar RP; Chandrasekaran A
    Psychiatry Res; 2016 Jun; 240():209-213. PubMed ID: 27111215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2*A1 allele.
    Young RM; Lawford BR; Barnes M; Burton SC; Ritchie T; Ward WK; Noble EP
    Br J Psychiatry; 2004 Aug; 185():147-51. PubMed ID: 15286066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.
    Bressan RA; Erlandsson K; Spencer EP; Ell PJ; Pilowsky LS
    Psychopharmacology (Berl); 2004 Sep; 175(3):367-73. PubMed ID: 14997280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.
    Zhang JP; Robinson DG; Gallego JA; John M; Yu J; Addington J; Tohen M; Kane JM; Malhotra AK; Lencz T
    Schizophr Bull; 2015 Nov; 41(6):1248-55. PubMed ID: 26320194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia.
    Osmanova DZ; Freidin MB; Fedorenko OY; Pozhidaev IV; Boiko AS; Vyalova NM; Tiguntsev VV; Kornetova EG; Loonen AJM; Semke AV; Wilffert B; Bokhan NA; Ivanova SA
    BMC Med Genet; 2019 Apr; 20(Suppl 1):47. PubMed ID: 30967134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinaemia in first episode psychosis - A longitudinal assessment.
    Lally J; Ajnakina O; Stubbs B; Williams HR; Colizzi M; Carra E; Fraietta S; Gardner-Sood P; Greenwood KE; Atakan Z; Mondelli V; Ismail K; Howes O; Taylor DM; Smith S; Hopkins D; Murray RM; Gaughran F
    Schizophr Res; 2017 Nov; 189():117-125. PubMed ID: 28755878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinemia in Children and Adolescents with Use of Risperidone: Clinical and Molecular Genetics Aspects.
    dos Santos Júnior A; Henriques TB; de Mello MP; Ferreira Neto AP; Paes LA; Della Torre OH; Sewaybricker LE; Fontana TS; Celeri EH; Guerra Júnior G; Dalgalarrondo P
    J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):738-48. PubMed ID: 26682995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between prolactin response and clinical efficacy of risperidone in acute psychotic inpatients.
    Lee BH; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):658-62. PubMed ID: 16466670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.